Mariusz Piotr Łochowski

Dr. Mariusz Piotr Łochowski


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Journal of Thoracic Disease
Verified
Journal Article
Closed access
PDF file
MŁMariusz Piotr Łochowski
Mariusz Piotr Łochowski
BŁBarbara Łochowska
Barbara Łochowska
IZIzabela Zawadzka
Izabela Zawadzka
BCBartosz Cieślik-Wolski
Bartosz Cieślik-Wolski
DKDominika Kozik
Dominika Kozik
JKJózef Kozak
Józef Kozak
Background: The aim of the study was to determine a prognostic value of the neutrophil to lymphocyte ratio (NLR), the platelet to lymphocyte ratio (PLR) and the lymphocyte to monocyte ratio (LMR) ratios for survival of patients, operated on due to non-small cell lung cancer (NSCLC). Methods: The study was conducted on 532 patients, operated on due to NSCLC, in stages IA–IIIA. A total of 174 females and 358 males, aged 36–84 years (the mean age: 63.6 years) were included in the study. The following factors were subject to a statistical analysis, conducted for determination of potential prognostic values of NLR, PLR and LMR ratios: age, sex, nicotinism, the number of leukocytes, neutrophils, monocytes, platelets, histopathological diagnosis, T category, N category, the Charlson comorbidity index (CCI), kind of surgery, patient survival. Results: The single-factor analysis revealed a relationship between NLR, PLR and LMR values, CCI values, the number of monocytes and the length of survival. The multi-factor analysis confirmed that for patients with expected 2-year survival, PLR above 138 (P=0.0008) is another negative prognostic factor, apart from the stage of the neoplastic disease and CCI above 4. For 5-year survival, such a relationship was not observed. Conclusions: The PLR ratio is an independent and significant prognostic factor for expected, over 2-year survival of patients operated on due to NSCLC.

1 October 2021 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
MŁMariusz Piotr Łochowski
Mariusz Piotr Łochowski
JCJustyna Chałubińska-Fendler
Justyna Chałubińska-Fendler
IZIzabela Zawadzka
Izabela Zawadzka
BŁBarbara Łochowska
Barbara Łochowska
MRMarek Rębowski
Marek Rębowski
JKJózef Kozak
Józef Kozak
Introduction:: The aim of the study was to determine the prognostic significance of PLR and NLR ratios in patients operated due to non-small cell lung cancer. Material: The study group consisted of 532 (174 women, 358 men) patients with non-small cell lung cancer (NSCLC) staged IA-IIIA. The mean age was 63.6 years (range 36 to 84 years). Together with platelet/lymphocyte ratio (PLR) and neutrophil/lymphocyte ratio (NLR), the following factors were included in the statistical analysis: age, sex, smoking history, the number of leukocytes, neutrophils, and platelets, histopathology, T-stage, N-stage, concomitant diseases according to the Charlson Comorbidity Index (CCI), type of operation, adjuvant chemotherapy, and overall survival. Results: Univariate analysis showed an association between the value of PLR and NLR and the length of survival. Multivariate analysis found that the stage of advancement of the neoplastic disease (p=0.00003), adjuvant chemotherapy (p=0.009), CCI > 4 (0.00008), and PLR > 144 (p=0.001) were negative prognostic factors for survival > 2 years; however, this effect diminishes in patients surviving more than 5 years. Conclusion: PLR might serve as a prognostic factor in patients affected by NSCLC with expected two-year overall survival.

23 July 2014 in Videosurgery and Other Miniinvasive Techniques
Verified
Journal Article
Open access
MŁMariusz Piotr Łochowski
Mariusz Piotr Łochowski
JKJózef Kozak
Józef Kozak
Video-assisted thoracic surgery (VATS) is a miniinvasive technique commonly applied worldwide. Indications for VATS are very broad and include the diagnosis of mediastinal, lung and pleural diseases, as well as large resection procedures such as pneumonectomy. The most frequent complication is...

1 March 2020 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
MŁMariusz Piotr Łochowski
Mariusz Piotr Łochowski
JCJustyna Chałubińska-Fendler
Justyna Chałubińska-Fendler
BŁBarbara Łochowska
Barbara Łochowska
IZIzabela Zawadzka
Izabela Zawadzka
DBDaniel Brzeziński
Daniel Brzeziński
JKJózef Kozak
Józef Kozak
Background: The aim of the study was to determine a survival prognostic value of selected blood morphological rates of patients, operated on due to non-small cell lung cancer (NSCLC). Methods: The study was conducted on 532 patients, surgically treated due to NSCLC, in stages IA–IIIA, 174 females and 358 males, mean age 63.6 years (36–84 years) were included in the study. Blood parameters and clinical factors were included in statistical analysis, in order to determine potential prognostic values of red blood cell distribution width-standard deviation (RDW-SD), mean corpuscular volume (MCV) of red cell and hemoglobin. Factors contained: age, sex, smoking history, histopathological diagnosis, T category, N category, age-adjusted Charlson Comorbidity Index (CCI), number of lymphocytes, neutrophils, monocytes, platelets, the neutrophil to lymphocyte ratio (NLR) and the platelet to lymphocyte ratio (PLR), kind of surgery, patient survival. Results: The univariate analysis revealed a dependence of the value of RDW-SD and CCI values, the number of monocytes, NLR and PLR values, neoplasia stage and the overall survival. The multivariate analysis confirmed that not only N2 category and the value of CCI above 4 are negative prognostication factors, but also RDW-SD above 43 fL (P=0.00007) and PLR above 138 (P=0.001) are such negative factors of survival prognosis. Conclusions: RDW-SD is an independent and significant prognostic factor of patients’ survival operated on due to NSCLC.

4 October 2012 in Digestive Diseases and Sciences
Verified
Journal Article
Open access
PDF file
Anna MokrowieckaAnna Mokrowiecka
Anna Mokrowiecka
SZSarah Zonnur
Sarah Zonnur
LVLothar Veits
Lothar Veits
JMJacek Musial
Jacek Musial
RKRadzislaw Kordek
Radzislaw Kordek
Arndt HartmannArndt Hartmann
Arndt Hartmann
Background Histopathologic differentiation between the stages of Barrett’s carcinogenesis is often challenging. Liver–intestine (LI)-cadherin, an intestine-specific marker, is involved in intestinal metaplasia development in gastric and colon cancers and could be of value in diagnosis and differentiation. Aims To examine the expression of LI-cadherin in the sequence of Barrett’s carcinogenesis and to evaluate its association with clinicopathological data. Methods LI-cadherin expression was immunohistologically investigated, by use of anti-CDH17 antibody, in gastric mucosa (GM) biopsies taken from the cardia (n = 9), in Barrett’s esophagus (BE) without intraepithelial neoplasia (without IEN) (n = 9) and BE with low-grade IEN (n = 11), and in esophageal adenocarcinoma (ADC) (n = 13). Results The immunoreactivity score was highest in adenocarcinoma (mean IRS = 4.0), and dropped gradually from BE with IEN and BE without IEN (mean IRS = 2.0) to cardia mucosa (IRS = 0). Similarly, the intensity of staining and the percentage of positive cells increased during the sequential stages of BE carcinogenesis. Comparative analysis showed that LI-cadherin expression was significantly different between cardiac epithelium and ADC. Also, percentage of positive cells in GM was significantly different from that in BE with IEN. LI-cadherin IRS was lower for tumors with poor differentiation than for moderately differentiated tumors, but the difference was not statistically significant. Conclusions LI-cadherin is a sensitive marker of intestinal metaplasia and can be helpful for early histologic diagnosis of Barrett’s esophagus; it is, however, not significantly different between BE with and without IEN, and cannot be used to distinguish between these.

1 June 2018 in Journal of Thoracic Disease
Verified
Journal Article
Closed access
PDF file
MŁMariusz Piotr Łochowski
Mariusz Piotr Łochowski
BŁBarbara Łochowska
Barbara Łochowska
MRMarek Rębowski
Marek Rębowski
DBDaniel Brzeziński
Daniel Brzeziński
BCBartosz Cieślik-Wolski
Bartosz Cieślik-Wolski
JKJózef Kozak
Józef Kozak
Background: The aim of the study is to analyse 5-year survival and prognostic factors in patients operated due to lung cancer with postoperatively confirmed metastases to N2 group nodes. Methods: In the years 2007–2015, 1,148 patients with lung cancer were treated surgically. A postoperative histopathological study confirmed N2 feature in 150 patients. One hundred and ten patients, in whom a 5-year survival analysis was possible to perform, were included in such analysis. The patients underwent the following procedures: pneumonectomy, 31 patients; lobectomy, 61; bilobectomy, 10; and wedge resection, 8. All patients were subjected to supplementary treatment after the surgery. Results: Five-year survival was achieved in 23 patients (21%). The patients’ survival did not depend on the type of surgery, type of tumour, its location or presence of metastases in N1 nodes (P=0.82, P=0.51, P=0.36 and P=0.23, respectively). A statistically significant correlation was observed (P=0.01) between the 5-year survival of a patient and the occurrence of metastases only in one group of lymph nodes of the N2 feature (22 patients, 20%). Involvement of three or more mediastinal nodal groups resulted in survival shorter than 5-year. Conclusions: (I) In patients with the N2 feature, the type of performed surgery, type of tumour and the occurrence of metastases in the lymph nodes of the lung hilum do not affect 5-year survival; (II) involvement of only one nodal group allows to achieve 5-year survival in 20% of patients; (III) involvement of three and more nodal groups with the N2 feature results in decreased 5-year survival.